Drug Information Association Logo
Corporate Tagline

Session 9, Part I – Real World Evidence: The Building Blocks

Track:
General Session

Day & Time:
January 15, 8:30AM - 10:00AM

Type:
Session

Title:
Session 9, Part I – Real World Evidence: The Building Blocks

Chair(s):
Mariette Boerstoel-Streefland, MD,MBA,MS
Consultant
MBS Drug Safety Consulting , United States

Description:
Session 9, Part I – Real World Evidence: The Building Blocks

Presentation(s) & Speaker(s):
PROTECT
Robert Reynolds, DrSc,MSc,FISPE
Vice President, Global Head, Epidemiology
Pfizer Inc, United States

FDA Sentinel Initiative: Status Update
Katrina Mott
FDA, United States

Partnerships Between Pharma and Database Owners
Andres Gomez
Head of Epidemiology, Signal Detection and Data Management
Bristol Myers Squibb, United States